MedPath

Is the addition of running retraining to best standard care beneficial in runners with medial tibial stress syndrome? a randomised controlled trial

Not Applicable
Recruiting
Conditions
Medial Tibial Stress Syndrome
Musculoskeletal - Other muscular and skeletal disorders
Physical Medicine / Rehabilitation - Physiotherapy
Registration Number
ACTRN12624000230550
Lead Sponsor
a Trobe University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
64
Inclusion Criteria

(i)have a clinical diagnosis of MTSS; according to subjective history and clinical examination:
- presence of exercise-induced pain along the tibial periosteum
- pain provoked by (during or after) physical activity and reduced with relative rest
- diffuse tenderness on palpation of the tibial periosteum
(ii)have running as a primary exercise activity, participating in running greater than, or equal to, twice per week
(iii)have a history of MTSS that has affected their running activity for greater than, or equal to, four weeks
(iv)have pain consistent with MTSS rated greater than, or equal to, 3 out of 10 on a numeric pain rating scale (NPRS)
(v)be willing to commit to an eight-week strengthening program that requires completion a minimum of twice per week
(vi)be agreeable to not receive any other forms of treatment for the duration of the trial
(vii)have an ability to understand written and spoken English

Exclusion Criteria

(i)any co-existing lower limb injury in the past three months that limits running participation
(ii)an inability to attend the required follow-up sessions
(iii)the presence of any symptoms suggestive of alternate lower leg pathology inclusive of stress fracture; cramping or burning pain; paraesthesia; severe swelling or erythema
(iv)an inability to run due to the severity of symptoms

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Running ability [University of Wisconsin Running Injury and Recovery Index Baseline, week 2, week 4 (primary timepoint) and week 8 post randomisation]
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath